ALL

News

Ponatinib back on the market

Ariad Pharmaceuticals, Inc., has begun shipping the drug to Biologics, Inc., its exclusive specialty pharmacy.

News

Genetic events drive ALL subtype

a patient with ALL Investigators have identified the genetic events leading to leukemic transformation in ETV6-RUNX1 acute lymphoblastic leukemia...

Conference Coverage

CAR-T cells drive ALL into remission

Major finding: Anti-CD19 chimeric antigen receptor T cells induced complete responses in 10 of 16 children and young adults with relapsed/...

Pages